| 000 | 01755 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514003402.0 | ||
| 264 | 0 | _c20010809 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a0007-1048 | ||
| 024 | 7 |
_a10.1046/j.1365-2141.2001.02826.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLopes, L F | |
| 245 | 0 | 0 |
_aAnalysis of Vgamma/Jbeta trans-rearrangements in paediatric patients undergoing chemotherapy. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cJun 2001 |
||
| 300 |
_a1001-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnthracyclines _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGene Rearrangement, beta-Chain T-Cell Antigen Receptor |
| 650 | 0 | 4 | _aGene Rearrangement, gamma-Chain T-Cell Antigen Receptor |
| 650 | 0 | 4 | _aGenetic Markers |
| 650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xchemically induced |
| 650 | 0 | 4 |
_aRhabdomyosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aSarcoma, Ewing _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aDias Neto, E | |
| 700 | 1 | _aLorand-Metze, I | |
| 700 | 1 | _aLatorre, M R | |
| 700 | 1 | _aSimpson, A J | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 113 _gno. 4 _gp. 1001-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2141.2001.02826.x _zAvailable from publisher's website |
| 999 |
_c11371336 _d11371336 |
||